Bionano GenomicsBNGOW 64 Days Inventory is 142.85 as of Mar. 2026, which is 29% below its 10-year median of 200.24. GuruFocus rates BNGOW with a GF Score™ of 64/100. The stock has 3 warning signs investors should review. Among 784 Medical Devices & Instruments companies, Bionano Genomics ranks better than 52.04% on this metric.
The historical rank and industry rank for Bionano Genomics's Days Inventory or its related term are showing as below:
BNGOW'
s Days Inventory Range Over the Past 10 Years
Min: 57.88 Med: 200.24 Max: 361.93
Current: 172.44
During the past 10 years, Bionano Genomics's highest Days Inventory was 361.93. The lowest was 57.88. And the median was 200.24.
BNGOW's Days Inventory is ranked better than 52.04% of 784
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs BNGOW: 172.44
Bionano Genomics's Days Inventory
declined
from Mar. 2025 (268.16) to Mar. 2026 (142.85).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Bionano Genomics's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.64.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bionano Genomics's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.80.
Bionano Genomics (NAS:BNGOW) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Bionano Genomics's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Bionano Genomics's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Bionano Genomics Days Inventory Related Terms
Bionano Genomics Days Inventory Historical Data
* Premium members only.
The historical data trend for Bionano Genomics's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BNGOW vs UEEC, CUPR, FEMY: Days Inventory Comparison
For the Medical Instruments & Supplies subindustry, Bionano Genomics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bionano Genomics Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bionano Genomics's Days Inventory distribution charts can be found below:
* The bar in red indicates where Bionano Genomics's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bionano Genomics (BNGOW) has a Days Inventory of 142.85 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bionano Genomics and its competitors. This is 29% below median its historical median of 200.24. Over the past decade, Bionano Genomics' Days Inventory has ranged from 57.88 to 361.93. According to the industry distribution chart, Bionano Genomics ranks #376 out of 784 companies in the Medical Devices & Instruments industry, placing it in the top 48%.
Is Bionano Genomics' Days Inventory too high?
Bionano Genomics' current Days Inventory of 142.85 is 29% below median its 10-year median of 200.24. Over the past 10 years, this metric has ranged from a low of 57.88 to a high of 361.93. The Medical Devices & Instruments industry median Days Inventory is 179.12. Bionano Genomics' value of 142.85 is 20.2% below this industry median. Based on the distribution chart, Bionano Genomics ranks #376 out of 784 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Bionano Genomics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.
How does Bionano Genomics' Days Inventory compare to UEEC and CUPR?
According to the Medical Devices & Instruments industry distribution chart, Bionano Genomics ranks #376 out of 784 companies for Days Inventory. This puts Bionano Genomics in the upper half of its industry. The industry median Days Inventory is 179.12. Bionano Genomics' value of 142.85 is 20.2% below this benchmark. Historically, Bionano Genomics' own Days Inventory has ranged from 57.88 to 361.93 over the past decade. While the company's 10-year median is 200.24 vs. the industry median of 179.12, Bionano Genomics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 784 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bionano Genomics's current Days Inventory of 142.85 is 20.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Bionano Genomics and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionano Genomics's current Days Inventory is 142.85, which is 29% below median its own 10-year median of 200.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionano Genomics stock overvalued right now?
Bionano Genomics (BNGOW) has a current Days Inventory of 142.85. The current Days Inventory is 142.85, which is 29% below median its 10-year median of 200.24 and 20.2% below the Medical Devices & Instruments industry median of 179.12. Bionano Genomics' overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Bionano Genomics (BNGOW), the current Days Inventory is 142.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
64GF Score
Get the complete analysis for BNGOW
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BNGOW has been successfully added to your 
